C5838621
influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension [Flucelvax Quadrivalent 2021-2022]
Concept
Cross-maps
Source vocabularies
Atoms not loaded for this concept.
Related concepts
Common questions
What is the UMLS CUI for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension [Flucelvax Quadrivalent 2021-2022]?
influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension [Flucelvax Quadrivalent 2021-2022] is coded as C5838621 in UMLS.
What is UMLS code C5838621?
C5838621 is the UMLS identifier for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Suspension [Flucelvax Quadrivalent 2021-2022]. It is included in the current NLM UMLS Metathesaurus release.
What is the RxNorm mapping for C5838621?
C5838621 maps to RxNorm 2654756.